cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Johnson Johnson
527 own
477 watching
Current Price
$156.33
$3.98
(2.61%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
364,320.59M
52-Week High
52-Week High
175.97000
52-Week Low
52-Week Low
143.13000
Average Volume
Average Volume
5.55M
Dividend Yield
Dividend Yield
0.025332
P/E Ratio
P/E Ratio
24.4496
iconMarket Capitalization364,320.59M
icon52-Week High175.97000
icon52-Week Low143.13000
iconAverage Volume5.55M
iconDividend Yield0.025332
iconP/E Ratio24.4496
What does the Johnson Johnson do?
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the health care field worldwide. It operates through three segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment offers baby care products under the JOHNSON'S brand; oral care products under the LISTERINE brand; beauty products under the AVEENO, CLEAN & CLEAR, DABAO, JOHNSON'S Adult, LE PETITE MARSEILLAIS, NEUTROGENA, RoC, and OGX brands; over-the-counter medicines, including acetaminophen products under the TYLENOL brand; cold, flu, and allergy products under the SUDAFED brand; allergy products under the BENADRYL and ZYRTEC brands; ibuprofen products under the MOTRIN IB brand; and acid reflux products under the PEPCID brand. This segment also provides women's health products, such as sanitary pads under the STAYFREE and CAREFREE brands, and tampons under the o.b. brand; wound care products comprising brand adhesive bandages under the BAND-AID brand and first aid products under the NEOSPORIN brand. The Pharmaceutical segment offers various products in the areas of immunology, infectious diseases and vaccines, neuroscience, oncology, and cardiovascular and metabolic diseases. The Medical Devices segment provides orthopaedic products; general surgery, biosurgical, endomechanical, and energy products; electrophysiology products to treat cardiovascular disease; sterilization and disinfection products to reduce surgical infection; diabetes care products that include blood glucose monitoring and insulin delivery products; and disposable contact lenses. The company markets its products to general public, retail outlets and distributors, wholesalers, hospitals, and health care professionals for prescription use, as well as for use in the professional fields by physicians, nurses, hospitals, eye care professionals, and clinics. Johnson & Johnson was founded in 1885 and is based in New Brunswick, New Jersey.
Read More
How much money does Johnson Johnson make?
News & Events about Johnson Johnson.
Zolmax
1 year ago
Birmingham Capital Management Co. Inc. AL cut its holdings in Johnson & Johnson (NYSE:JNJ Get Rating) by 1.6% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 45,548 shares of the companys stock after selling 750 shares during the period. Johnson...
Zolmax
1 year ago
Wallace Advisory Group LLC bought a new position in shares of Johnson & Johnson (NYSE:JNJ Get Rating) during the fourth quarter, according to its most recent filing with the SEC. The fund bought 7,946 shares of the companys stock, valued at approximately $1,404,000. Johnson & Johnson accounts for 1....
Globe Newswire
1 year ago
According to the settlement agreement, AVT04 (ustekinumab) can be marketed in the US, subject to regulatory approval, no later than February 21, 2025 REYKJAVIK, Iceland and TEL AVIV, Israel and PARSIPPANY, N.J., June 12, 2023 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company ...
Globe Newswire
1 year ago
According to the settlement agreement, AVT04 (ustekinumab) can be marketed in the US, subject to regulatory approval, no later than February 21, 2025 Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, and ...
Zolmax
1 year ago
Parallel Advisors LLC raised its holdings in Johnson & Johnson (NYSE:JNJ Get Rating) by 4.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 58,591 shares of the companys stock after purchasing an additional...
Frequently Asked Questions
Frequently Asked Questions
What is Johnson Johnson share price today?
plus_minus_icon
Can Indians buy Johnson Johnson shares?
plus_minus_icon
How can I buy Johnson Johnson shares from India?
plus_minus_icon
Can Fractional shares of Johnson Johnson be purchased?
plus_minus_icon
What are the documents required to start investing in Johnson Johnson stocks?
plus_minus_icon
What is today’s traded volume of Johnson Johnson?
plus_minus_icon
What is today’s market capitalisation of Johnson Johnson?
plus_minus_icon
What is the 52-Week High and Low Range of Johnson Johnson?
plus_minus_icon
What percentage is Johnson Johnson down from its 52-Week High?
plus_minus_icon
What percentage is Johnson Johnson up from its 52-Week Low?
plus_minus_icon
Current Price
$156.33
$3.98
(2.61%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00